---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-24-000026"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2024-04-15T23:59:59+00:00"
generated_at: "2026-06-03T23:05:03.303918+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AEON Biopharma sets warrant redemption FMV at $7.6994, cashless ratio 0.2456

## Summary
- Redemption Fair Market Value calculated at $7.6994 per Public Warrant under Warrant Agreement Section 6.2.
- Cashless exercise yields approximately 0.2456 shares of common stock per Public Warrant.
- Redemption date remains April 29, 2024; unexercised warrants void and holders receive $0.10 each.
- Supplemental notice follows initial redemption announcement on March 29, 2024.

## SEC filing metadata
- accession: 0001837607-24-000026
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2024-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760724000026/0001837607-24-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760724000026/aeon-20240415x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-24-000026
- JSON: https://secwatch.observer/filing/0001837607-24-000026.json
- Plain text: https://secwatch.observer/filing/0001837607-24-000026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.